One shot: could a single radiation dose control metastatic cancer?
NCT ID NCT07671768
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a single, high-dose radiation treatment guided by MRI for solid tumors that have spread. It aims to see if the treatment is safe and can control tumors outside the brain and spine. The trial will enroll 25 adults with 1 to 3 metastases, each no larger than 5 cm.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiation therapy (MR-guided stereotactic body radiation therapy)
- What this could lead to
- If it works, this could offer a faster, one-day radiation option to control metastatic tumors outside the brain and spine.
- What could go wrong
- This is a very small, early safety trial with only 25 people. It may not work for all tumor types, and there is a risk of side effects from high-dose radiation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tracer that hunts unstable iron light up hidden tumors?
- Vaccine trains immune system to hunt down cancer cells
- Gut radiation may revive immunotherapy in resistant cancers
- Can talking about stress ease Cancer's mental toll? new study aims to find out
- Mayo clinic hunts for hidden cancer clues in DNA and proteins
- New drug targets hard-to-treat cancers in early trial